Show Notes
Nature staff discuss how an FDA-approved drug for narcolepsy could have promise beyond the condition, and the longest-lived human brain organoids yet.
00:28 The promise of a new narcolepsy drug Nature: First-of-its-kind narcolepsy drug opens door to new therapies for the brain
05:53 Human brain organoids kept alive for over five years Nature: Human organoids that mimic brain development grown for years in lab
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. Hosted on Acast. See acast.com/privacy for more information.
More from Nature Podcast
In this episode:
Critical thinking is a skill that is under threat from the AI revolution in large language models. But all is not lost. Specialists in education and cognition have long been studying critical thinking, and some have useful tips on how to stay cognitively sharp in the age of AI.
In this episode:
Analysis suggests number of protected areas is hugely underestimated but biodiversity is still in peril — plus, a huge study looking at the health effects of brown fat. 00:45 The world may have more conservation areas than previously thought Research Article: O’Neill et al.
In this episode we discuss a recent Nature exclusive investigating an international constellation of sham academies and societies that have successfully misled some of the world’s leading scientists and universities. Nature: Exclusive: Sham scientific societies are misleading star researchers